WW International is launching a platform that integrates its wellness program with GLP-1 drugs. Should you buy the stock now?

During President Donald Trump's year-end address Wednesday evening, he touted several economic wins for his administration, including "unprecedented price reductions" of prescription drugs and the ...

Chipotle is rolling out its first-ever High Protein Menu — and it's tying the launch to the rise of GLP-1 weight-loss drugs ...

Currently, we’re not we’re not expecting or we’re not thinking about marketing it to our guests,” the CEO said. “Because it’s ...

In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," talks with Christle Guevarra, DO, MS, about her struggle with weight, her journey with GLP-1 drugs, and her career in medicine.

Eli Lilly seeks FDA approval for orforglipron, a once-daily pill shown in trials to help maintain weight loss after stopping ...

As consumers drop pounds, beauty and wellness brands are dropping products in hopes of cashing in on the rise of weight-loss ...

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

From gut health and GLP-1 buzz to sensory snacks, solo meals, and the return of real meat, we crunched 2026’s trend reports ...

Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) are two prominent names in healthcare that have focused on innovation and ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...